Europace
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Device-detected atrial fibrillation before and after acute cardiac events: insights from ASSERT
2021
-
Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis
2019
-
In memoriam: Stuart J. Connolly, MD, 9 April 1949-2 June 2024.
26.
2024
-
Diagnostic reliability of monitoring for premature atrial and ventricular complexes.
26:euae198.
2024
-
Causes of death in patients with atrial fibrillation anticoagulated with rivaroxaban: a pooled analysis of XANTUS.
26:euae183.
2024
-
Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort.
26:euae102.014.
2024
-
Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial.
26:euae102.024.
2024
-
Dietary sodium intake and atrial myopathy.
26:euae102.017.
2024
-
Effects of long-term continuous screening for atrial fibrillation on heart failure events - results from the randomized LOOP Study.
26:euae102.050.
2024
-
Incidence and predictors of heart failure events following cardiac surgery in patients with atrial fibrillation - insights from the LAAOS-III trial.
26:euae102.051.
2024
-
Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness.
26:euae102.018.
2024
-
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference.
26:euae070.
2024
-
Durability of pulmonary vein isolation for atrial fibrillation: a meta-analysis and systematic review.
25:euad335.
2023
-
Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation.
25:euad200.
2023
-
Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation.
25:euad149.
2023
-
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke: comment—Authors’ reply.
25:778-778.
2023
-
Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis.
25:318-330.
2023
-
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference.
25:6-27.
2023
-
Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis.
24:1548-1559.
2022
-
Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study.
24:1475-1483.
2022
-
A clinical dilemma: the longer the higher the risk?—Authors’ reply.
24:1196-1197.
2022
-
Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke.
24:1058-1064.
2022
-
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
24:1112-1118.
2022
-
New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?.
24:1037-1037.
2022
-
Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study.
24:774-783.
2022
-
Electrocardiogram screening programme in detecting sudden cardiac disease in the young: cost efficiency and diagnostic yield—Authors’ reply.
24:524-525.
2022
-
Corrigendum to: Diagnostic yield and financial implications of a nationwide electrocardiographic screening program to detect cardiac disease in the young.
23:1301-1301.
2021
-
Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young.
23:1295-1301.
2021
-
Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
23:1200-1210.
2021
-
Antiplatelets in patients with atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials.
23:euab116.265.
2021
-
Post-operative pain following cardiac implantable electronic device implantation: insights from the BRUISE CONTROL trials.
23:748-756.
2021
-
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.
23:329-344.
2021
-
Mobile health applications for the detection of atrial fibrillation: a systematic review.
23:11-28.
2021
-
74Subclinical atrial fibrillation before and after acute medical illness or noncardiac surgery: insights from ASSERT.
22.
2020
-
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.
22:870-877.
2020
-
Atrial fibrillation and stroke: chicken or egg? Does it really matter?.
22:509-510.
2020
-
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events.
22:195-204.
2020
-
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
22:47-57.
2020
-
A proof of principle study of atomoxetine for the prevention of vasovagal syncope: the Prevention of Syncope Trial VI.
21:1733-1741.
2019
-
Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial.
21:1023-1030.
2019
-
Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons.
21:445-450.
2019
-
Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS.
21:421-427.
2019
-
Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
21:377-382.
2019
-
Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study.
20:1798-1803.
2018
-
Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
20:f240-f248.
2018
-
Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
20:1442-1450.
2018
-
Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
20:e87-e95.
2018
-
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.
20:963-970.
2018
-
The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey.
20:929-934.
2018
-
47Characteristics and outcomes of atrial fibrillation in patients without conventional risk factors: A RE-LY AF registry analysis.
20:i5-i5.
2018
-
ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts.
20:429-434.
2018
-
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.
20:253-262.
2018
-
Left atrial anatomy, atrial fibrillation burden, and P-wave duration—relationships and predictors for single-procedure success after pulmonary vein isolation.
20:271-278.
2018
-
Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey.
19:1922-1929.
2017
-
Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.
19:1630-1636.
2017
-
Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
19:1556-1578.
2017
-
P1380Gender differences in the progression of atrial fibrillation in low-risk paroxysmal AF patients with hypertension: the role of left ventricular hypertrophy.
19:iii269-iii270.
2017
-
P283The influence of progression of atrial fibrillation on quality of life: a report from the euro heart survey.
19:iii40-iii40.
2017
-
Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial.
19:euw116-euw116.
2017
-
Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment.
19:euw072-euw072.
2017
-
Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis.
19:euw221-euw221.
2017
-
Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
18:973-978.
2016
-
The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial.
18:912-918.
2016
-
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
18:159-183.
2016
-
Usefulness of the Calgary Syncope Symptom Score for the diagnosis of vasovagal syncope in the elderly.
15:1210-1214.
2013
-
Duty-cycled bipolar/unipolar radiofrequency ablation for symptomatic atrial fibrillation induces significant pulmonary vein narrowing at long-term follow-up.
15:690-696.
2013
-
Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site.
14:1475-1482.
2012
-
Non-apical pacing: the right place to the right patient.
14:1376-1376.
2012
-
Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
14:682-689.
2012
-
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
14:666-674.
2012
-
Device-detected atrial tachyarrhythmias: what do we know?.
14:157-158.
2012
-
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
14:184-190.
2012
-
The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research.
13:601-602.
2011
-
The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation.
13:409-415.
2011
-
Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries.
13:23-30.
2011
-
Atrial overdrive pacing in sleep apnoea: a meta-analysis.
11:1037-1040.
2009
-
Comprehensive upstream treatment for atrial fibrillation, when and how?.
11:397-399.
2009
-
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.
10:403-411.
2008
-
Cardiac resynchronization therapy: left or left-and-right for optimal symptomatic effect the LOLA ROSE study.
9:862-868.
2007
-
Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope.
8:306-311.
2006
-
Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope Rationale and study design.
5:71-75.
2003
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)